0

Dyslipidemia Collection
 41-60 of 358 Articles
Reviews |  3 November 2009 FREE
Systematic Review: Comparative Effectiveness and Harms of Combination Therapy and Monotherapy for Dyslipidemia
Mukul Sharma, MD, MSc; Mohammed T. Ansari, MBBS, MMedSc, MPhil; Ahmed M. Abou-Setta, MD, PhD; et al.
Ann Intern Med. 2009;151(9):622-630. doi:10.7326/0003-4819-151-9-200911030-00144
Academia and the Profession |  18 August 2009 FREE
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and ElaborationPRISMA: Explanation and Elaboration
Alessandro Liberati, MD, DrPH; Douglas G. Altman, DSc; Jennifer Tetzlaff, BSc; et al.
Ann Intern Med. 2009;151(4):W-65-W-94. doi:10.7326/0003-4819-151-4-200908180-00136
Ideas and Opinions |  21 July 2009
Cholesterol Control Beyond the Clinic: New York City's Trans Fat Restriction
Sonia Y. Angell, MD, MPH; Lynn Dee Silver, MD, MPH; Gail P. Goldstein, MPH; et al.
Ann Intern Med. 2009;151(2):129-134. doi:10.7326/0003-4819-151-2-200907210-00010
Articles |  16 June 2009
Red Yeast Rice for Dyslipidemia in Statin-Intolerant Patients: A Randomized Trial
David J. Becker, MD; Ram Y. Gordon, MD; Steven C. Halbert, MD; et al.
Ann Intern Med. 2009;150(12):830-839. doi:10.7326/0003-4819-150-12-200906160-00006
Reviews |  16 June 2009
Narrative Review: Statin-Related Myopathy
Tisha R. Joy, MD; Robert A. Hegele, MD
Ann Intern Med. 2009;150(12):858-868. doi:10.7326/0003-4819-150-12-200906160-00009
Editorials |  16 June 2009
Balancing Randomized Trials With Anecdote
Paul S. Phillips, MD
Ann Intern Med. 2009;150(12):885-886. doi:10.7326/0003-4819-150-12-200906160-00014
Articles |  21 April 2009 FREE
Using a Drug Facts Box to Communicate Drug Benefits and Harms: Two Randomized Trials
Lisa M. Schwartz, MD, MS; Steven Woloshin, MD, MS; H. Gilbert Welch, MD, MPH
Ann Intern Med. 2009;150(8):516-527. doi:10.7326/0003-4819-150-8-200904210-00106
Editorials |  21 April 2009 FREE
Communicating Drug Benefits and Risks Effectively: There Must Be a Better Way
Jerry Avorn, MD; William H. Shrank, MD, MSHS
Ann Intern Med. 2009;150(8):563-564. doi:10.7326/0003-4819-150-8-200904210-00012
Reviews |  7 April 2009
Systematic Review: Association of Low-Density Lipoprotein Subfractions With Cardiovascular Outcomes
Stanley Ip, MD; Alice H. Lichtenstein, ScD; Mei Chung, MPH; et al.
Ann Intern Med. 2009;150(7):474-484. doi:10.7326/0003-4819-150-7-200904070-00007
Articles |  3 March 2009
Response to Newly Prescribed Lipid-Lowering Therapy in Patients With and Without HIV Infection
Michael J. Silverberg, PhD, MPH; Wendy Leyden, MPH; Leo Hurley, MPH; et al.
Ann Intern Med. 2009;150(5):301-313. doi:10.7326/0003-4819-150-5-200903030-00006
Articles |  17 February 2009
Comparing Impact and Cost-Effectiveness of Primary Prevention Strategies for Lipid-Lowering
Mark J. Pletcher, MD, MPH; Lawrence Lazar, MD; Kirsten Bibbins-Domingo, PhD, MD; et al.
Ann Intern Med. 2009;150(4):243-254. doi:10.7326/0003-4819-150-4-200902170-00005
Articles |  20 January 2009
High-Density Lipoprotein Particle Size and Concentration and Coronary Risk
Karim El Harchaoui, MD; Benoit J. Arsenault, MSc; Remco Franssen, MD; et al.
Ann Intern Med. 2009;150(2):84-93. doi:10.7326/0003-4819-150-2-200901200-00006
Articles |  6 January 2009
Association Between Statin Use and Risk for Keratinocyte Carcinoma in the Veterans Affairs Topical Tretinoin Chemoprevention Trial
David D. Dore, PharmD, PhD; Kate L. Lapane, PhD; Amal N. Trivedi, MD, MPH; et al.
Ann Intern Med. 2009;150(1):9-18. doi:10.7326/0003-4819-150-1-200901060-00004
Articles |  4 November 2008 FREE
Effects of an Oral Ghrelin Mimetic on Body Composition and Clinical Outcomes in Healthy Older Adults: A Randomized Trial
Ralf Nass, MD; Suzan S. Pezzoli, BA; Mary Clancy Oliveri, MS; et al.
Ann Intern Med. 2008;149(9):601-611. doi:10.7326/0003-4819-149-9-200811040-00003
Articles |  6 May 2008
Monitoring Cholesterol Levels: Measurement Error or True Change?
Paul P. Glasziou, MBBS, PhD; Les Irwig, MBBS, PhD; Stephane Heritier, PhD; et al.
Ann Intern Med. 2008;148(9):656-661. doi:10.7326/0003-4819-148-9-200805060-00005
Medicine and Public Policy |  15 April 2008
The International Pharmaceutical Market as a Source of Low-Cost Prescription Drugs for U.S. Patients
Aaron S. Kesselheim, MD, JD; Niteesh K. Choudhry, MD, PhD
Ann Intern Med. 2008;148(8):614-619. doi:10.7326/0003-4819-148-8-200804150-00006
Articles |  18 September 2007
Changes in Triglyceride Levels and Risk for Coronary Heart Disease in Young Men
Amir Tirosh, MD, PhD; Assaf Rudich, MD, PhD; Tzippora Shochat, MSc; et al.
Ann Intern Med. 2007;147(6):377-385. doi:10.7326/0003-4819-147-6-200709180-00007
Articles |  3 July 2007 FREE
Outcomes of Using High- or Low-Dose Atorvastatin in Patients 65 Years of Age or Older with Stable Coronary Heart Disease
Nanette K. Wenger, MD; Sandra J. Lewis, MD; David M. Herrington, MD; et al.
Ann Intern Med. 2007;147(1):1-9. doi:10.7326/0003-4819-147-1-200707030-00002
Articles |  3 July 2007
β-Blockers and Progression of Coronary Atherosclerosis: Pooled Analysis of 4 Intravascular Ultrasonography Trials
Ilke Sipahi, MD; E. Murat Tuzcu, MD; Katherine E. Wolski, MPH; et al.
Ann Intern Med. 2007;147(1):10-18. doi:10.7326/0003-4819-147-1-200707030-00003
Articles |  1 May 2007
Role of the Apolipoprotein B–Apolipoprotein A-I Ratio in Cardiovascular Risk Assessment: A Case–Control Analysis in EPIC-Norfolk
Wim A. van der Steeg, MD; S. Matthijs Boekholdt, MD, PhD; Evan A. Stein, MD, PhD; et al.
Ann Intern Med. 2007;146(9):640-648. doi:10.7326/0003-4819-146-9-200705010-00007
Advertisement
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)